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Abstract
More than 20 human neurological and neurodegenerative diseases are caused by simple DNA repeat expansions; among
these, non-coding CTG repeat expansions are the basis of myotonic dystrophy (DM1). Recent work, however, has also
revealed that many human genes have anti-sense transcripts, raising the possibility that human trinucleotide expansion
diseases may be comprised of pathogenic activities due both to a sense expanded-repeat transcript and to an anti-sense
expanded-repeat transcript. We established a Drosophila model for DM1 and tested the role of interactions between
expanded CTG transcripts and expanded CAG repeat transcripts. These studies revealed dramatically enhanced toxicity in
flies co-expressing CTG with CAG expanded repeats. Expression of the two transcripts led to novel pathogenesis with the
generation of dcr-2 and ago2-dependent 21-nt triplet repeat-derived siRNAs. These small RNAs targeted the expression of
CAG-containing genes, such as Ataxin-2 and TATA binding protein (TBP), which bear long CAG repeats in both fly and man.
These findings indicate that the generation of triplet repeat-derived siRNAs may dramatically enhance toxicity in human
repeat expansion diseases in which anti-sense transcription occurs.
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Introduction
Trinucleotide repeat expansions within non-coding regions of
RNA cause pathogenesis in a number of human diseases,
including myotonic dystrophy type 1 (DM1), fragile X-associate
tremor and ataxia syndrome (FXTAS), spinocerebellar ataxia type
8 (SCA8), and Huntington’s disease-like 2 (HDL2) [1-3]. The
causative mutations of DM1, SCA8 and HDL2 are CTG repeat
expansions. In DM1, the CTG expansion is located within the 39
untranslated region (39UTR) of the dystrophia myotonica-protein kinase
(DMPK) gene [4,5]. The expanded CUG repeat RNA forms
ribonuclear foci, and mislocalizes and misregulates RNA binding
proteins such as CUG-BP1 and MBNL1 that influence alternative
splicing [6-8]. Similarly, expanded CUG RNA also contributes to
pathophysiology of SCA8 and HDL2 [9,10]. These findings
indicate that CTG-based RNA expansion diseases may have the
accumulation of RNA foci, sequestration of MBNL1, and
disruption of alternative splicing as common components.
It is now recognized, however, that more than 70% of genomic
loci show evidence of transcription from both sense and anti-sense
strands in the mammalian genome [11], thus many of the
trinucleotide repeat disease loci may display bidirectional
transcription. Indeed, anti-sense transcripts have been detected
for most trinucleotide repeat disease loci, including DM1 and
SCA8 [12-16]. In DM1 cells, the sense and antisense transcripts
can cause regional chromatin modification [15]. In SCA8, an
antisense CAG transcript can be translated into a polyglutamine-
encoding protein [14]. Given that anti-sense transcription occurs
widely in the human genome [11,17,18], defining the range of
potential roles and impact of anti-sense repeat transcripts on
trinucleotide repeat diseases may provide novel insight into disease
pathogenesis.
Drosophila has proven a powerful system to reveal insight into
neurological and neurodegenerative disease with relevance to the
human situation [19-22]. Thus, to gain insight into CUG RNA
toxicity in the DM1 disease situation, we established transgenic
flies that express pure, uninterrupted CTG repeat expansions in
the 39UTR of a control protein DsRed. These flies recapitulate
major features of human CUG RNA expansion diseases. Given
the finding that ,70% of genes show anti-sense transcription, we
then tested the effect of co-expressing CTG and CAG disease
transcripts. These data revealed dramatically enhanced toxicity
upon co-expression of these transcripts; studies indicate this is due
to the generation of triplet repeat-derived siRNAs which can target
other repeat containing transcripts. These findings suggest that
sense and anti-sense expanded repeat transcripts may interact in
vivo to generate small RNAs that may dramatically enhance
pathology in disease situations.
Results
Expression of expanded CUG RNA causes repeat-length
dependent toxicity
To study CUG repeat RNA toxicity in flies, we generated UAS
constructs with a pure CTG repeat expansion of 250 in length,
(CTG)250, within the 39UTR of DsRed (Figure 1A). Due to
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repeat lengths and generated a series of transgenic lines that
together encompassed a range of CTG repeat lengths (Figure 1B).
Among these, we selected six lines bearing different repeat lengths
that expressed the transcript at comparable levels (Figure 1C and
1D).
With expression ubiquitously using daughterless-gal4 (da-gal4), in
the nervous system with elav-gal4, or in muscle with 24B-gal4,
repeat-length dependent lethality was observed (Table 1). When
expression was targeted selectively to the eye, the animals showed
abnormal eye pigmentation and disruption of retinal integrity, the
severity of which was dependent on repeat length (Figure 1E). Flies
bearing the longest repeats also showed variability in severity
which may be a feature of a pure repeat sequence (Figure 1E and
Figure S1, see Discussion). Taken together, these studies indicate
that non-coding, uninterrupted CTG repeats confer length-
dependent toxicity when expressed in brain and muscle in flies.
As in mammals, the expanded CTG repeat transcripts formed
RNA accumulations in muscle nuclei in flies (Figure S2A; also
[23,24]), and affected alternative splicing (Figure S2B and S2C).
These data indicate that the fly recapitulates fundamental key
features of the CTG expansion disease DM1 (also [23-25]).
Enhancement of CTG-repeat toxicity by CAG-repeat
transcripts
Bi-directional transcription is prevalent in the mammalian
genome and is thought to occur in DM1 [11,12,15,16]. We
therefore asked whether expression of a non-coding CAG repeat
transcript together with a CTG repeat transcript would have an
effect distinct from that of the CTG repeat transcript alone.
Toxicity of non-coding (CAG)250 repeat transcripts has been
previously characterized, as adult-stage late-onset neurological
dysfunction and loss [26]. Expression of either (CAG)250 or
(CTG)200 in the eye with gmr-gal4, however, causes minimal
effects (Figure 1E) [26]. Co-expression of (CTG)200 together with
a (CAG)250 transcript, however, resulted in dramatic toxicity: the
eye was now severely rough with abnormal pigmentation,
demonstrating severe loss of retinal integrity (Figure 2A). The
effect was synergistic, as expression of either two copies of a
(CAG)250 or two copies of (CTG)200 repeat alone had limited or
no effects (Figure S3). Additional combinations of repeat lengths
with gmr-gal4 indicated that co-expression of (CTG)250 or
(CTG)270 with (CAG)250 repeats caused lethality at pre-adult
pupal stages and/or generated adults with severely disrupted eyes,
depending upon the precise combination of transgenes (Figure 3A
and 3D, and data not shown). The interaction was dependent on
disease-length repeat expansions, since flies co-expressing small
(CTG)19 and (CAG)34 repeats did not show toxicity (Figure 2A).
A toxic interaction between CTG/CAG transcripts was also
seen using a heat shock driver in adults, and a muscle driver 24B.
Adult flies with a 30 min heat shock induction of (CAG)250 and
(CTG)250 transcripts started to die at ,24 h, with 90% flies dead
at 50 h (Figure 3B). In contrast, flies expressing (CAG)250 alone,
(CTG)250 alone or non-pathogenic (CTG)19/(CAG)34 tran-
scripts were not affected. In muscle, co-expression of (CAG)100
with (CTG)130 caused developmental lethality, while (CTG)19/
(CAG)34, (CAG)100, and (CTG)130 flies were viable (Figure 3C).
Taken together, these data indicate that co-expression of disease-
length CTG repeat transcripts together with comparable CAG
repeat transcripts causes synergistic pathogenesis.
CTG/CAG transcripts are processed into small RNAs
To define the basis of the enhanced toxicity upon co-expressed
CTG and CAG transcripts, we reasoned that the stability of each
transcript may become greater, such that each transcript then
displays greater toxicity. However, northern analysis indicated that
the levels of the full-length repeat mRNAs were reduced (Figure 2B
and Figure S4A), arguing against increased transcript stability
accounting for the enhanced toxicity.
A second possibility was that novel interactions between the two
transcripts were taking place, causing an effect distinct from either
transcript on its own. Small RNA northern analysis revealed that
small RNAs of ,21 nt, detected with either (CAG)5 or (CUG)5
probes, were generated in the co-expression situation (Figure 2C
and Figure S4B). These data indicated that expanded CAG and
CTG transcripts are processed into triplet repeat-derived small
RNAs when co-expressed.
Toxicity of co-expressed CTG/CAG transcripts is
dependent on Dcr2 and Ago2
Given that the CTG/CAG transcripts produced small RNAs,
we determined whether the enhanced toxicity as well as generation
of the small RNAs were dependent on dcr2, the enzyme in flies that
cleaves double-stranded RNA for siRNA biogenesis[27]. Flies
expressing (CTG)250/(CAG)250 with gmr-gal4 were lethal at late
developmental stages; dissection of animals from the pupal case
revealed severely disrupted eye morphology (Figure 3A). Flies
expressing the repeat transcripts, but homozygous mutant for dcr2
gene function, were now viable and displayed significantly restored
eye structure (Figure 3A). Homozygous loss of dcr2 activity also
rescued organismal lethality with heatshock induction of
(CTG)250/(CAG)250 transcripts, and rescued developmental
lethality upon expression of (CTG)130/(CAG)100 transcripts in
muscle (Figure 3B and 3C). Loss of dcr2 had a minimal or no effect
on toxicity of (CTG)250 alone, (CAG)250 alone or a mutant tau
protein, the latter being associated with frontotemporal dementia
(Figure S5A and S5B and data not shown). This indicates that dcr2
function is required for the toxicity associated with CTG/CAG co-
expression. The dcr2 null background also blocked the biogenesis
of the triplet repeat-derived small RNAs generated upon co-
expression of the two transcripts, restoring the full length repeat
RNA levels, concomitant with mitigation of toxicity (Figure 3E
and 3F).
Author Summary
Over 20 diseases are caused by the expansion of simple
repeat sequences in the human genome. Among these are
the polyglutamine protein diseases and other primarily
RNA–based diseases like myotonic dystrophy (DM1) and
spinocerebellar ataxia type 8 (SCA8). Recently, it has also
become clear many genes are transcribed into RNAs from
both strands. These include genes causing DM1 and SCA8.
Small interfering RNAs (siRNAs) are short RNAs that are
cleaved from double-stranded RNAs. These siRNAs can
direct degradation of other complementary RNA sequenc-
es to reduce their expression. To study consequences of bi-
directional transcription of pathogenic repeat sequences,
we introduced repeat RNAs containing both CUG and CAG
in a Drosophila model of DM1. We found that these repeat
RNAs can be cleaved into repeat-derived siRNAs that are
highly toxic to the animal. The mechanisms include
targeting RNAs of other genes containing simple repeat
sequence for degradation. These findings indicate that
repeat-derived siRNAs generated from bidirectional tran-
scription may, in a disease situation, contribute novel
pathogenic components.
Toxic Triplet Repeat-Derived siRNAs in DM1
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whether they were methylated at the 39 end, a modification
specific to siRNAs loaded to Ago2-RISC [28]. They were resistant
to oxidation/ß-elimination normally, but sensitive to ß-elimination
in the hen1 mutant background which prevents methylation
(Figure 3G and Figure S4C), arguing that the repeat-derived
small RNAs are siRNAs and are assembled into the Ago2-RISC
complex. Further, loss of ago2 also dramatically mitigated
(CTG)200/(CAG)250 toxicity (Figure 3D and Figure S6). To
address specificity, we determined whether genes that modulate
the miRNA pathway contributed to the CTG/CAG interaction.
Reduction in gene dosage of dcr1 or ago1 showed no effect (data
not shown). In addition, whereas upregulation of dcr2 dramatically
enhanced CTG/CAG toxicity with concomitant increase of the
triplet repeat-derived small RNAs, there was no effect of dcr1
upregulation (Figure S7). These data suggest that the triplet
repeat-derived small RNAs are siRNAs in nature and that their
toxic effects are dependent on Dcr2 and Ago2 activity.
Triplet repeat derived siRNAs compromise the expression
of genes containing short CAG stretches
We tested whether the siRNAs may be competing with
endogenous small RNAs for the biogenesis machinery, and thus
by a titration mechanism causing toxicity. However, up-regulation
of dcr2, which should suppress according to a titration mechanism,
instead enhanced toxicity of expanded CTG/CAG (see Figure S7).
Moreover, generation of miRNAs, with analysis of miR-277 and
miR-8, and generation of endogenous small RNAs, with analysis of
hp-CG4068B and esiRNA-sl-1 (dependent on dcr2 activity [29]),
were not affected upon co-expression of the CTG/CAG
Figure 1. CTG repeat transcripts cause repeat-length dependent toxicity. A. DNA constructs for DM1 fly model. A pure, uninterrupted CTG
repeat was placed in the 39UTR of a control protein DsRed. B. Southern blot, probed with DsRed sequence, was used to determine CTG repeat length
in transgenic lines. w
1118 was the negative control. C. Northern blot to determine RNA expression levels. 39UTR sequence was used as the probe. D.
Western blot to compare DsRed protein level. Heat shock, with a hs-gal4 driver, was used for expression in B–D. E. External eye and internal retinal
structure of flies expressing distinct length CTG repeat transcripts at 1d (top panels) and 14d (bottom panels). Genotypes of flies from left to right:
Gmr-gal4 in trans to, UAS-DsRed-(CTG)19, UAS-DsRed-(CTG)130, UAS-DsRed-(CTG)200, UAS-DsRed-(CTG)230, UAS-DsRed-(CTG)270. The effect of UAS-
DsRed-(CTG)270 was variable (see also Figure S1); shown here are examples of mild (m) and severe (s) effects. Arrows highlight necrotic patches on
external eyes and loss of retinal tissue internally.
doi:10.1371/journal.pgen.1001340.g001
Table 1. Length-dependent toxicity of CTG repeats in
different tissues.
Tissue type CTG repeat number
19 130 200 230 250 270
muscle 222+/2 +/2 +/2
neuronal 22++ + + + + +
ubiquitous 22++ ++ ++ ++
Transgenic lines bearing the specific repeat lengths noted were outcrossed to
driver gal4 lines that selectively express in specific tissues. Muscle expression
was with 24B-gal4, neural expression with elav-gal4, and ubiquitous expression
with da-gal4.
Key: 2, viable; +/2, semi-lethal; +, pupal lethal; ++, larval lethal.
doi:10.1371/journal.pgen.1001340.t001
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also not affected in flies expressing expanded CTG/CAG
(Figure 4B), suggesting that the RNA interference pathways in
these flies were largely intact. Together, these data argue that
overwhelming endogenous RNA interference pathways cannot
account for the enhanced toxicity.
In light of the requirement for ago2 and dcr2, we then asked
whether the triplet repeat-derived siRNAs targeted other tran-
scripts with small CAG or CUG stretches, such that disruption or
loss of the activity of those genes may subsequently caused the
deleterious effects. We selected two endogenous fly genes which,
like their human counterparts, contain CAG repeat stretches, atx2
(containing (CAG)9) and tbp (containing (CAG)5CAA(CAG)2), and
analyzed their expression levels by realtime PCR. In flies
expressing expanded CTG/CAG transcripts, the levels of these
CAG-containing mRNAs were downregulated ,60–70%; tran-
scripts without such repeats and control transcripts such as tubulin
and appl were unaffected (Figure 4B). Further analysis revealed
that the atx2 and tbp transcripts were being cleaved within their
CAG repeat stretches in flies expressing expanded CTG/CAG
repeats in a dcr-2 dependent manner (Figure 4C and 4D). In
contrast, we did not observe down-regulation of CUG containing
transcripts by realtime PCR nor did we detect cleavage of these
transcripts by RLM-RACE in flies expressing expanded CTG/
CAG (data not shown; see Discussion). These data indicate that
co-expression of CTG/CAG repeat transcripts generates triplet
repeat-derived siRNAs that target other CAG-containing tran-
scripts within the genome; deleterious effects on the levels and
activity of these genes may contribute to the pathogenic effects of
genes with expanded repeats that are bi-directionally transcribed.
Discussion
Like many genes within the mammalian genome [11], the DM1
gene displays bi-directional transcription, generating an anti-sense
CAG repeat transcript in addition to the disease-associated CTG
transcript [15]. These transcripts have been shown to interact in
human cells to generate small RNAs, with one effect being local
gene silencing [15]; however additional ways in which this may
contribute to pathogenicity in disease is largely unknown. In order
to provide new insight into DM1, we generated a Drosophila model
by expressing pure, uninterrupted CTG repeat expansions; fly
models for various disorders have revealed critical insight into a
number of human disease situations (Clark et al., 2006;
Fernandez-Funez et al., 2000; Jin et al., 2003; Meulener et al.,
2005; Warrick et al., 1998). Interestingly, targeted expression of
the long CTG repeats in the fly eye caused a variable toxic effect
(see Figure S1). This was also observed in a fly model of SCA8,
which carries an uninterrupted CTG repeat expansion [30]. In
contrast, fly models generated using interrupted CTG repeats
were not reported to show variable phenotype [24,25]. It is thus
possible that phenotypic variability may be a feature of pure repeat
sequences, which is in line with the fact that DM1 is among the
most variable human disorders. To define potential effects of bi-
directional transcription, we then co-expressed expanded CAG
repeat transcripts with the DM1 CTG repeats. This resulted in
dramatically enhanced toxicity concomitant with the generation of
triplet repeat-derived siRNAs. Our results are in striking contrast
with previous findings that co-expression of CGG and CCG
expansions in flies leads to mitigated toxicity in a ago2-dependent
manner [31], suggesting that toxicity derived from interactions
between sense and anti-sense repeat transcripts may be specific to
CTG/CAG situations. Both CAG and CUG strands can be
processed into ,21 nt small RNAs when coexpressed and small
RNAs derived from both strands are methylated in a Hen1-
dependent manner (see Figure 2C, Figure 3G, Figure S4B and
S4C). These results suggest that both CAG and CUG small RNAs
can be loaded into mature, holo-RISCs presumably due to the
symmetrical thermodynamic properties of the repeat small RNA
duplex [28,32-34]. In our studies, we detected direct cleavage of
Figure 2. Interaction between expanded CAG and CTG repeat transcripts causes biogenesis of small RNAs. A. External eye (top) and
internal retinal sections (bottom). Left, co-expression of transgenes with short repeats shows no deleterious effect. Right, co-expression of expanded
(CAG)250 with expanded (CTG)200 repeat transcripts leads to a disrupted eye externally, with severe loss of retinal integrity internally. Genotypes:
left, gmr-gal4 in trans to UAS-DsRed-(CTG)19 UAS-DsRed-(CAG)34 and right, gmr-gal4, UAS-DsRed-(CTG)200/+; UAS-DsRed-(CAG)250/+. Age of flies: 1d.
B. Northern blot. The expression level of the (CTG)250 transcript is reduced when co-expressed with the (CAG)250 transcript. *: a non-specific band
overlapping with Dsred-(CTG)19. C. Small repeat RNAs were generated when expanded CAG and CTG repeat transcripts were co-expressed.
Genotype of flies in B and C: hs-gal4 in trans to UAS-DsRed-(CTG)19 UAS-DsRed-(CAG)34, w
1118, UAS-DsRed, UAS-DsRed-(CAG)250, UAS-DsRed-(CTG)250
and UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)250.
doi:10.1371/journal.pgen.1001340.g002
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PLoS Genetics | www.plosgenetics.org 4 March 2011 | Volume 7 | Issue 3 | e1001340Figure 3. Toxicity and small RNA biogenesis of co-expressed CTG and CAG transcripts are dependent on dcr2 and ago2. A. Loss of
dcr2 rescues the toxicity caused by co-expression of (CAG)250 and (CTG)250. With normal dcr2 gene function (wildtype), (CAG)250(CTG)250 caused
lethality at the pre-adult pupal stage, with dissected animals showing severely disrupted eyes externally and internally. In the dcr2 null background,
these flies were now viable and displayed a dramatically improved retinal structure. Genotypes: gmr-gal4 in trans to UAS-DsRed-(CTG)250 UAS-DsRed-
(CAG)250 in normal or homozygous dcr2 null background. Age of flies: 1d. B. Mutation of dcr2 also rescued lethality of flies co-expressing expanded
Toxic Triplet Repeat-Derived siRNAs in DM1
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cleavage of CUG containing transcripts mediated by CAG small
RNAs (see Figure 4B–4D). Although underlying reasons for this
differential effect remain unclear, CUG and CAG transcripts may
have differential expression levels or translation efficiencies, and/
or CUG-containing and CAG-containing transcripts may be
associated with different RNA binding proteins of various
affinities, making CUG-transcripts less accessible to the RISC
complex than CAG-containing transcripts [35]. A number of
CUG-binding proteins have been defined, such as MBNL1,
CUGBP1 and PKR [36-38]. Interestingly, in-vitro gel retardation
analysis indicated that MBNL1 has a much lower affinity for CAG
repeat RNA than CUG repeat RNA[36]. Moreover, expanded
CAG transcripts, although co-localizing with MBNL1 in ribo-
nuclear foci similarly to expanded CUG transcripts, do not appear
to cause mis-regulation of alternative splicing in cells[39], further
highlighting differential properties of these repeats in interacting
with RNA binding proteins.
The toxicity caused by co-expression of expanded CAG and
CTG was associated with deleterious effects on transcripts of other
CAG containing genes within the genome; additional mechanisms
that contribute to toxicity may also exist. A large number of genes
contain CAG stretches in fly and human genomes (Table S1 and
Table S2). The enhanced toxicity we observed in flies expressing
expanded CAG and CTG may therefore be reflecting an additive
effect of knockdown of multiple CAG-containing genes, with each
individual gene contributing only partially to the overall outcome.
Although further reducing atx2 dosage did not enhance toxicity of
co-expressed CTG/CAG expansions (ZY and NB, unpublished
observations), the compromised activities of many target genes
may be involved and further compromising any single one has
minimal impact. The toxic effects seen of the CAG/CTG situation
may also be complicated by the later-onset and progressive nature
of the toxicity. Further study will clarify the contribution of this
mechanism, and key targets among all possible transcripts, to the
overall phenotype of the disease. Moreover, the deleterious effects
caused by triplet repeat derived small RNAs may be further
exacerbated by the wide prevalence of CAG stretches in the
human transcriptome (Table S2) and the relative low specificity of
RNA interference when siRNAs and/or RNA targets contain
simple repeats like CAG [40,41]. Such interactions may represent
a novel activity of endo-siRNAs that characterize disease situations
where bi-directional transcription spanning the repeat region
occurs (Figure 4E).
We confirmed that two of CAG containing genes, atx2 and tbp,
are targets of the triplet repeat-derived siRNAs. Interestingly,
CAG repeat expansions in ATXN2 (the human Ataxin-2 gene) and
TBP define two of the CAG-repeat expansion diseases (SCA2 and
SCA17, respectively). In such diseases, the expanded polygluta-
mine domain is thought to confer toxicity [1,2]; however,
increasing evidence suggests that the loss-of-function of gene
activity, and not just dominant activities of the protein with an
expanded polyglutamine region, occur in disease [42,43]. Our
findings raise the possibility that bi-directional transcription of the
repeat region in diseases like DM1 may confer additional
components of pathogenicity due to deleterious interactions
between the two overlapping repeat-containing transcripts
through the generation and activity of triplet repeat-derived
siRNAs.
Studies indicate that bi-directionally transcribed RNAs, and
presumably resultant endogenous double-stranded RNAs, are
processed into ,21–23 nt small RNAs in human cells [44,45].
This is despite the fact that in most mammalian cells, long
exogenous double-stranded RNAs can elicit the interferon
response [46,47]. That response presumably occurs in a
threshold-dependent manner; cells may also respond differentially
to long exogenous double-stranded RNAs versus endogenous
double-stranded RNAs. Thus, these findings suggest that the
biogenesis pathway of small RNAs from endogenous double-
stranded RNAs is conserved in mammalian cells. Many loci are bi-
directionally transcribed throughout the mammalian genome
[11,17,18], and among these are a number of human trinucleotide
disease genes, including SCA8 and DM1 [12,16]. In SCA8, an
anti-sense transcript is proposed to encode a polyglutamine
protein, which itself may have deleterious actions [14]. In DM1,
the two transcripts interact to produce small RNAs that can have
local effects on gene silencing [15]. Our findings raise another
possibility, that processing of co-expressed transcripts containing
CUG/CAG expansions into triplet repeat-derived siRNAs in vivo,
may contribute to toxicity with widespread deleterious effects.
These effects may include downregulating the expression of other
genes containing CAG repeats. Among the genes that could be
targets are the polyglutamine disease genes themselves, one of
which is TBP. Expansion of the TBP polyglutamine repeat
underlies SCA17 [48]; intriguingly, general transcriptional com-
promise has been shown to be a component of repeat expansion
diseases [49,50]. Our studies raise the possibility that perhaps
another reason why these diseases share transcriptional compro-
mise may be that they share bi-directional transcript interactions
that compromise common elements like TBP. This possibility
underscores the idea of shared therapeutic targets and mechanisms
in repeat expansion diseases.
It has been proposed that siCAG and siCUG may be used for
therapy of triplet repeat expansion diseases based on findings in
cell culture that these siRNAs seem to specifically target mutant
transcripts with expanded repeats [51]. Our data suggest caution
in designing such siRNA-based therapy, as in the intact
organismal situation, pathogenic activities may be noted. Although
repeat transcripts. Survival of adult flies was scored 50 hr after 30 min heatshock induction of transgene expression with hs-gal4.* :p,0.01 when
compared to dcr2 null background. ANOVA and Newman-Keuls post-test. Genotypes: hs-gal4 in trans to UAS-DsRed-(CAG)34 UAS-DsRed-(CTG)19,
2xUAS-DsRed-(CAG)250, 2xUAS-DsRed-(CTG)250, and UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)250 in normal or homozygous dcr2 background. C. Co-
expression of (CAG)100 and (CTG)130 in muscle with 24B-gal4 leads to developmental lethality, which is rescued by dcr2 mutation. Genotype of
parental flies: 24B-gal4 : UAS-DsRed-(CAG)34 UAS-DsRed-(CTG)19/TM6B, Tb. 24B-gal4 : 2xUAS-DsRed-(CTG)130/TM6B, Tb. 24B-gal4/TM6B, Tb : 2xUAS-
DsRed-(CAG)100. 24B-gal4 : 2xUAS-DsRed-(CAG)100 UAS-DsRed-(CTG)130/ TM6B, Tb. dcr2
L811fsX; 24B-gal4/ TM6B, Tb : dcr2
L811fsX; UAS-DsRed-(CAG)100
UAS-DsRed-(CTG)130/TM6B, Tb.* :p,0.05 when compared to flies in wildtype background. ANOVA and Newman-Keuls post-test. D. Homozygous loss
ago2 suppressed the toxicity caused by co-expression of (CAG)250 and (CTG)200, with flies showing improved external eye. Flies were raised at 29 uC.
Age of flies: 1d. Genotypes: gmr-gal4 in trans to UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)200 in normal or homozygous ago2 null background. E. Loss of
dcr2 restored levels of full-length repeat transcripts. Head RNA was subject to Northern blot. 18S rRNA, loading control. F. Biogenesis of triplet repeat-
derived small RNAs is dcr2-dependent. Small RNA isolated from fly heads was analyzed by Northern blot. 2S rRNA, loading control. Genotypes E and F:
hs-gal4 in trans to UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)250 in wildtype or dcr2 null background. G. Triplet repeat-derived small RNAs were
methylated at the 39 end by Hen1 shown by oxidation and ß-elimination reactions. Small RNA from heads was analyzed by Northern blot and probed
with (CAG)5. Note that triplet repeat-derived small RNAs from hen1 null mutants run as a range of faster-migrating species after ß-elimination. 2S
rRNA blot served as the control. Genotype: hs-gal4 in trans to UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)270.
doi:10.1371/journal.pgen.1001340.g003
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processed into small RNAs, [51], our data suggest that both
expanded CAG and CTG are required for triplet repeat-derived
siRNA generation and toxicity in vivo (see Figure 2C and Figure
S5). Thus, co-expressed CAG and CTG expansions may
contribute to DM1 pathogenesis through a fundamentally
different mechanism from that of CTG expansions alone.
Although our studies were conducted in fly models, the findings
may apply to human trinucleotide expansion diseases. Targeting
these diseases at the transcriptional level may therefore be a
Figure 4. Expression of expanded (CAG) and (CTG) repeat transcripts disrupts expression of genes containing short triplet repeat
stretches. A. Biogenesis of the endogenous siRNAs, hp4068B and esiRNA-sl-1, and microRNAs, miR-277 and miR-8, is not affected in flies co-
expressing CAG with CTG repeat transcripts. Genotypes: Hs-gal4 in trans to UAS-DsRed-(CAG)34 UAS-DsRed-(CTG)19, w
1118, UAS-DsRed, UAS-DsRed-
(CAG)250, UAS-DsRed-(CTG)250 and UAS-DsRed-(CAG)250 UAS-DsRed-(CAG)250. B. Levels of transcripts containing short (CAG) stretches are reduced in
flies co-expressing (CAG)250(CTG)250. Two transcripts containing at least five consecutive (CAG) repeats, atx2 and tbp, were chosen for analysis.
Retrotransposon 412, ß-tubulin and appl were included as controls. Realtime PCR on fly head RNA, 9 hr after heat shock. Genotypes: Hs-gal4 in trans
to UAS-DsRed, UAS-DsRed-(CAG)250, UAS-DsRed-(CTG)250, UAS-DsRed-(CAG)250 UAS-DsRed-(CAG)250. (*: p,0.01, **: p,0.001, compared to DsRed.
ANOVA and Bonferroni’s post test, n=4). C. Dicer-2 dependent cleavage of transcripts of tbp and atx2 in flies co-expressing expanded CAG/CTG
transcripts as determined by RLM-RACE assay. Genotypes: hs-gal4 in trans to: w
1118, UAS-DsRed-(CAG)34 UAS-DsRed-(CTG)19 and UAS-DsRED-(CAG)250
UAS-DsRED-(CTG)250 in either wild type or dcr2 null background. Nested PCR products were analyzed on agarose gels; bands labeled with asterisk
were reproducible among four repeat experiments. They were sequenced and confirmed to be derived from cleaved transcripts of atx2 and tbp.D .
Cleavage sites on transcripts of atx2 and tbp mapped by sequence analysis of PCR products of the RLM-RACE assay. Frequencies of cleavage at certain
sites are shown in the linear map of atx2 and tbp transcripts. Black boxes represent CAG rich regions. Atx2 has multiple splicing isoforms and isoform
B is the form abundantly expressed in fly heads. E. A model for repeat toxicity in CTG diseases that includes possibility of anti-sense CAG transcripts.
Sense transcripts containing the CUG repeat RNA expansion exert toxicity through misregulation of RNA binding proteins such as Muscleblind and
CUG-BP1, resulting in aberrant alternative splicing [1,7,10,14,56]. Antisense transcripts containing CAG repeat expansions could be translated into
toxic polyglutamine proteins (as in SCA8 [14]) and they may also be toxic on their own [26]. Our data here suggest that CTG and CAG transcripts may
also interact, leading to the generation of ,21 nt triplet repeat derived siRNAs, which may target other transcripts that contain CAG repeat stretches
through the RNA interference pathway.
doi:10.1371/journal.pgen.1001340.g004
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effects of single expanded repeat transcripts, but deleterious
interactions between sense and anti-sense repeat transcript
domains.
Materials and Methods
Fly lines
General fly lines were ordered from public stock centers and
maintained at 25 uC on standard medium unless otherwise
indicated. CTG repeats of various length (DNA templates kindly
provided by C. Thornton, University of Rochester) were inserted
into the 39UTR of DsRed2 gene (Clontech) in pUAST. All
transgenic constructs were confirmed by sequencing. Fly lines were
generated by P-element mediated transformation. Repeat lengths
were determined by Southern blot and confirmed by Genescan for
select lines showing variability. dcr2
L811fsX, ago2
414, Hen1 mutant
Pimet
f00810, UAS-dcr1, UAS-dcr2, UAS-DsRed-(CAG)100 and
UAS-DsRed-(CAG)250 lines are described [26,27,52-54].
Western, Southern, and Northern blots
Standard techniques were used. Primary antibodies for
Westerns were anti-DsRed (1:400, anti-rabbit, Clontech), anti-
actin (1:4,000, anti-mouse, Abcam). HRP conjugated secondary
anti-mouse (1:4000, Chemicon) and anti-rabbit antibodies (1:4000,
Zymed) were used with ECL+ reagents (Amersham). For Southern
blots, genomic DNA was extracted from ,50 flies using the
Gentra Puregene Cell Kit (Qiagen) and 5 mg of genomic DNA was
fully digested with 200 units of EcoRI and XbaI. DsRed DNA was
PCR amplified using primers: forward 59-GGCCCCCTGCC-
CTTCGCC-39 and reverse 59-CTACAGGAACAGGTGGTG-
GCGG-39, purified using QIAquick Gel Extraction Kit (Qiagen)
and labeled using the High Prime DNA Labeling Kit (Roche
Applied Science). For Northern blots, flies were heatshocked at
37 uC for 30 min and allowed to recover at 25 uC for 20 h. Total
RNA was extracted using Trizol Reagent (Invitrogen) from either
whole flies (for comparing transgene levels among various lines) or
heads. 2–10 mg of total RNA was loaded on 1% denaturing
formaldehyde/MOPS agarose gels for regular Northern blots. For
small RNA Northerns, total RNA was further purified using the
mirVana miRNA Isolation Kit (Ambion) to enrich small RNA.
100 ng small RNA was loaded on 15% TBE-Urea polyacrylamide
gel (Invitrogen). The SV40 probe for Northern blots was PCR
amplified using primers: forward 59-TGTGGTGTGACA-
TAATTGGACA-39 and reverse 59-AGATGGCATTTCTTCT-
GAGCA-39, purified using QIAquick Gel Extraction Kit (Qiagen)
and labeled using the High Prime DNA Labeling Kit (Roche
Applied Science). Other probes for Northern blot were made using
the MAXIscript Kit (Ambion) from the annealed double stranded
DNA template containing T7 promoter. Oligo sequences were:
T7 promoter forward oligo: 59-GATAATACGACTCACTA-
TAGGGAGA-39
r(CAG)5 probe: 59-GGGGGCTGCTGCTGCTGCTGTCTC-
CCTATAGTGAGTCGTATTATC-39
r(CUG)5probe: 59-GGGGGCAGCAGCAGCAGCAGTCTC-
CCTATAGTGAGTCGTATTATC-39
2S rRNA: 59-TGCTTGGACTACATATGGTTGAGGGTT-
GTATCTCCCTATAGTGAGTCGTATTATC-39
18S rRNA: 59-AGGGAGCCTGAGAAACGGCTACCACA-
TCTAAGGAATCTCCCTATAGTGAGTCGTATTATC-39
hp4068B: 59-TTGACTCCAACAAGTTCGCTCCTCTCCC-
TATAGTGAGTCGTATTATC-39
mir277: 59-TAAATGCACTATCTGGTACGACATCTCCC-
TATAGTGAGTCGTATTATC-39.
In situ hybridization
In-situ hybridization was performed as described [26].
Radioactive PCR
Radioactive PCRfor the alternative splicing assay was performed
as described [55]. Total RNA was extracted from fly heads using
RNeasy Mini Kit (Qiagen) and cDNA was synthesized using the
SuperScript First-Strand Synthesis for RT-PCR (Invitrogen).
Primers used for radioactive PCR reaction were: forward 59-
GCCATTTGACCATTCACCACATTGGTGTG-39, reverse 59-
TTGCTGGAGCATAGCACTCTTCAGGTG-39. The forward
primer was labeled using the T4 polynucleotide kinase (New
England Biolabs). PCR reactions were run 21–23 cycles and
separated on 5% non-denaturing TBE polyacrylamide gels. The gel
was then dried and exposed to Storage Phosphor Screens (GE
Healthcare). Band densitometry was quantified using Image J
(NIH).
Real-time PCR
0-3d flies were heatshocked at 37 uC for 30 min and recovered
at 25 uC for 9 h. Total RNA was extracted from fly heads using
Trizol Reagent (Invitrogen), treated with Turbo DNase (Ambion)
and further purified using the mirVana miRNA Isolation Kit
(Ambion). cDNA was synthesized in a 20 ml reaction volume from
0.2 mg of total RNA using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems). 0.2 ml of cDNA was used
as the template in a 20 ml reaction volume diluted from the Power
SYBR Green PCR Master Mix Kit (Applied Biosystems). Real-
time PCR was performed in triplet or quadruplicate using a 7500
Fast Real-Time PCR System (Applied Biosystems). Data were
analyzed using the DDCt method. Endogenous control was rp49.
Each experiments was repeated at least three times on indepen-
dent RNA preparations.
Real-time PCR primers were designed using the Primer Express
software (Applied Biosystems) and the sequences were:
atx2 forward: 59-CGCACGCGCGATAACC-39
atx2 reverse: 59-AGTTGGAAGTCCTGGCCAAA-39
tbp forward: 59-AAGCTCGGTTTCCCTGCAA-39
tbp reverse: 59-GCAGGAGCCGACCATGTTT-39
412 forward: 59-CACCGGTTTGGTCGAAAG-39
412 reverse: 59-GGACATGCCTGGTATTTTGG-39
appl forward: AGGTCACGCGCGTTATGAA
appl reverse: GGCGCATGTCCTGGTACTTC
ß-tubulin forward 59-CATCCAAGCTGGTCAGTGC-39
ß-tubulin reverse 59-GCCATGCTCATCGGAGAT-39
rp49 forward: 59-CAACATCGGTTACGGATCGA-39
rp49 reverse: 59-AATCCGGTGGGCAGCAT-39
RNA ligase mediated amplification of cDNA ends (RLM-
RACE)
To detect cleavage of atx2 and tbp transcripts, RLM-RACE and
cloning of RLM-RACE products were carried out using the
GeneRacer Kit (Invitrogen, Carlsbad, CA). Briefly, 3-4d flies were
heatshocked at 37 uC for 30 min and then maintained at 25 uC
for 14 hr. Total RNA was extracted from fly heads using the
RNAeazy kit (Qiagen, Valencia, CA). The 59 GeneRacer RNA
adaptor molecule was ligated onto the total RNA population.
Ligated products were reverse transcribed using random primers
and nested PCR was performed using primers derived from the 59
GeneRace adaptor and gene specific primers, respectively, to
detect RISC cleavage products. PCR products were analyzed on
1% agarose TAE gel. To analyze cleavage sites, PCR products
were gel purified using the gel purification kit (Qiagen, Valencia,
Toxic Triplet Repeat-Derived siRNAs in DM1
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CA) and sequenced. Primers used for nested PCR were:
dTBPclv5RACEnest1: 59-GGGCCCATCGTCTGGTGGAT-
GTT-39
dTBPclv5RACEnest2: 59-TGGTGGATGTTGCTCAGGGC-
ATCT-39
dAtx2clv5RACEnest1: 59-TGTGGCGGCGGCATTGTATG-
GTAAA-39
dAtx2clv5RACEnest2: 59-TGTGGCGGCGGCTGCTGCAC-
TT-39
GeneRacer59 Primer: 59-CGACTGGAGCACGAGGACAC-
TGA-39
GeneRacer59 nested Primer: 59-GGACACTGACATGGACT-
GAAGGAGTA-39
59 GeneRacer RNA adaptor: 59-CGACUGGAGCACGAG-
GACACUGACAUGGACUGAAGGAGUAGAAA-39
Heatshock survival assay
0-3d flies were heat shocked at 37 uC for 30 min and then
maintained at 25 uC for 50 hr. Numbers of dead/living flies were
recorded. At least ,100 flies were scored for each genotype and
the experiments were repeated three times.
Viability assay
24B-gal4 driver flies were outcrossed to flies of appropriate
genotype and progeny flies were scored for viability. At least 100
progeny flies were scored for each cross and experiments were
repeated three times.
Supporting Information
Figure S1 Variable effect of flies expressing (CTG)270 repeat
transcripts in the eye. (A) Representative images of mild, medium
and severe eyes of the flies expressing the (CTG)270 repeat in the
eye with gmr-gal4. Severe were eyes that were smaller in size with
more pigmentation loss, less organized and rougher eye surface
than flies with mild effects. Retinal sectioning confirmed that the
internal retinal structure correlated with the degree of disruption
of the external eye. 1d flies of genotype gmr-gal4/UAS-DsRed-
(CTG)270. (B) Percentage of flies in each category. 740 female flies
were scored. Repeat length of parental males was 265–273 by
genescan (data not shown). Both male and female flies showed
variability; shown here are females.
Found at: doi:10.1371/journal.pgen.1001340.s001 (1.09 MB TIF)
Figure S2 Expanded CUG repeat RNA accumulate in the nuclei
and affect alternative splicing. (A) RNA foci in flies expressing
expanded CTG repeat transcript. Body-wall muscles of 3
rd instar
larvae were stained with propidium iodide to highlight nuclei (left
panel), and FAM-labeled (CAG)7 probe for CUG RNA accumu-
lation (right panel). CTG transcripts accumulate in (CTG)230 but
not in control (CTG)19 larvae. Foci were sensitive to RNase A but
resistant to DNase I treatment. Genotype: 24B-gal4/UAS-DsRed-
(CTG)230, 24B-gal4/UAS-DsRed-(CTG)19 and 24B-gal4/UAS-
DsRed-(CTG)270 (B) Structure of the minigene construct for the
splicing assay. The human cTNT minigene reporter (kindly
provided by T Cooper) was subcloned into pUAST vector for
transgenesis. In fly photoreceptor neurons, exon 2 of sTNI was
alternatively spliced, resulting in either 110 bp or 140 bp RT-PCR
product using the primers indicated. (C) Expression of expanded
CUG RNA promoted exclusion of exon 2 of sTNI as indicated by
the ratio of 140 bp/110 bp. A representative radioactive gel image
was shown on top right corner of the chart. Genotypes: Rh1-gal4
UAS-hcTNT in trans to (lane 1) w
1118, (lane 2) UAS-DsRed-(CTG)19,
(lane 3) UAS-DsRed-(CTG)270; UAS-DsRed-(CTG)250 and (lane 4)
2xUAS-DsRed-(CTG)250. Quantification of 3 independent experi-
ments is shown. (* p,0.05, * * p,0.01 comparing to (CTG)19;
ANOVA and Dunnett’s post test).
Found at: doi:10.1371/journal.pgen.1001340.s002 (1.35 MB TIF)
Figure S3 Expression of two copies of (CAG)250 or (CTG)200
transcripts alone did not cause an effect as severe as that of co-
expression of (CAG)250 together with (CTG)200. External eyes
and internal retinal structure. Genotypes: gmr-gal4 in trans to (left)
2xUAS-DsRed-(CAG)250 and (right) 2xUAS-DsRed-(CTG)200. Com-
pare to eyes in Figure 3A, which shows that co-expression of short
CAG and CTG transcripts has no effect, while co-expression of
long (CAG)250 with (CTG)200 transcripts is severely toxic.
Expression of a single copy of the (CAG)250 transcript in the
eye has minimal effects, expression of a single copy of the
(CTG)200 transcript is shown in Figure 1E.
Found at: doi:10.1371/journal.pgen.1001340.s003 (1.30 MB TIF)
Figure S4 Repeat derived siRNAs are generated when CTG is
co-expressed with CAG. (A) Northern blot. The expression level of
the (CAG)250 transcript is reduced when co-expressed with the
(CTG)250 transcript. The blot was also probed with DsRed to
compare the relative level between (CAG)250 and (CUG)250. (B)
,21 nt small repeat RNAs were generated as probed by (CUG)5
when expanded CAG and CTG repeats were co-expressed.
Genotype: hs-gal4 in trans to UAS-DsRed-(CTG)19 UAS-DsRed-
(CAG)34, w
1118, UAS-DsRed, UAS-DsRed-(CAG)250, UAS-DsRed-
(CTG)250 and UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)250 (C)
Triplet repeat-derived small CAG RNAs were methylated at the
39 end by Hen1 shown by oxidation and ß-elimination reactions.
Small RNA from heads was analyzed by Northern blot and probed
with(CUG)5. 2S rRNA blot servedas the control. Genotype: hs-gal4
in trans to UAS-DsRed-(CAG)250 UAS-DsRed-(CTG)270.
Found at: doi:10.1371/journal.pgen.1001340.s004 (0.55 MB TIF)
Figure S5 Mutations of dcr2 or ago2 have minimal effects on
toxicity of the expanded CTG transcript and tauR406W. (A) Loss
of dcr2 does not block eye degeneration caused by expression of
(CTG)250 transcripts. Arrows highlight black necrotic patches on
the eye surface. age of flies: 14d animals. Genotypes: gmr-gal4,
UAS-DsRed-(CTG)250 in normal or homozygous dcr2 background.
(B) Loss of dcr2 has a minimal effect on toxicity due to expression
of mutant tau R406W. Age of flies: 1d. Genotypes: gmr-gal4, UAS-
tauR406W in normal or homozygous dcr2 background. (C) Loss of
ago2 does not prevent eye degeneration caused by expression of
(CTG)270. Loss of pigmentation and disorganization of omma-
tidia were similar between wildtype and ago2 null flies expressing
the (CTG)270 transcript. Shown are eyes with severe phenotype in
both genotypes. Genotypes: gmr-gal4, UAS-DsRed-(CTG)270 in
normal or homozygous ago2 background.
Found at: doi:10.1371/journal.pgen.1001340.s005 (2.30 MB TIF)
Figure S6 Loss of ago2 suppresses CTG/CAG toxicity. (A)
Survival rate of flies expressing various transgenes by hs-gal4 was
scored 50 h after heatshock induction of transgene expression.
*: p,0.05 when compared to flies in null ago2 background;.
Statistics: ANOVA and Newman-Keuls post-test. Genotype of
flies: hs-gal4 in trans to: UAS-DsRed-(CAG)34 UAS-DsRed- (CTG)19,
UAS-DsRed-(CAG)250/ UAS-DsRed-(CAG)250, UAS-DsRed-
(CTG)250/UAS-DsRed-(CTG)250, UAS-DsRed-(CAG)250 UAS-
DsRed-(CAG)270 in either wildtype or ago2 null background. (B)
Internal eye degeneration of (CTG)200/(CAG)250 is suppressed
in ago2 null flies. 1d animals. Genotypes: gmr-gal4 in trans to UAS-
DsRed-(CAG)250 UAS-DsRed-(CTG)200 in normal or homozygous
ago2 null background. 29 uC.
Found at: doi:10.1371/journal.pgen.1001340.s006 (0.57 MB TIF)
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(CAG)250 and increases levels of triplet repeat derived small
RNAs in flies expressing (CTG)130/(CAG)100. (A) Flies coex-
pressing expanded CAG/CTG transcripts with added dcr2 activity
showed severe eye disruption. In contrast, upregulation of dcr1 had
little effect. Genotypes: from left to right gmr-gal4 UAS-DsRed-
(CTG)200; UAS-DsRed-(CAG)250 in trans to w
1118, UAS-dcr2 and
UAS-dcr1. (B) Dcr2 upregulation increases levels of triplet repeat
derived small RNAs. Genotype of flies: hs-gal4/UAS-DsRed-
(CAG)100 UAS-DsRed-(CTG)130 either with or without UAS-dcr2.
Found at: doi:10.1371/journal.pgen.1001340.s007 (1.88 MB TIF)
Table S1 Fly genes that contain CAG or CUG repeats. List of
fly genes that contain 7 or more CAG or CUG repeats in at least
one of the splicing variants was obtained by performing a BLAST
search of the Drosophila melanogaster Refseq_RNA database using
(CAG)7 as the query sequence. Gene accession numbers were
converted to gene names using the Gene ID Conversion Tool
(http://david.abcc.ncifcrf.gov/conversion.jsp).
Found at: doi:10.1371/journal.pgen.1001340.s008 (0.23 MB
DOC)
Table S2 Human genes that contain CAG or CUG repeats. List
of human genes that contain 7 or more CAG or CUG repeats in at
least one of the splicing variants was obtained by performing a
BLAST search of the Homo sapiens Refseq_RNA database using
(CAG)7 as the query sequence. Gene accession numbers were
converted to gene names using the Gene ID Conversion Tool
(http://david.abcc.ncifcrf.gov/conversion.jsp).
Found at: doi:10.1371/journal.pgen.1001340.s009 (0.19 MB
DOC)
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